Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany
Business Of Biotech
00:00
Sizzola MAB - What's a Special in MAB?
The discovery of Sizzola MAB actually started back in 2009. It's a very inspiring story of following the science and leading you then to the right patient population. And this is something we need to work on, you know, all together with the entire healthcare system to improve our ability to diagnose this disease so that all the patients that could benefit from it can access it.
Transcript
Play full episode
